Nathalie Rousselet
Paris, 75012, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Restoring chloride efflux in cystic fibrosis with TMEM16a antisense oligonucleotides.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 05, 2025
Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway.
Journal: Microbes and infection
Published: May 12, 2023
miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis.
Journal: Frontiers in immunology
Published: August 20, 2019
Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients.
Journal: Frontiers in pharmacology
Published: March 23, 2018
Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways.
Journal: The Journal of pathology
Published: October 31, 2017
FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 20, 2017
MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology.
Journal: Nature communications
Published: August 17, 2016
New insights about miRNAs in cystic fibrosis.
Journal: The American journal of pathology
Published: May 07, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026